COMPANIESGARUDA THERAPEUTICS, INC.
✓ Verified H1B Sponsor

GARUDA THERAPEUTICS, INC.

Cambridge, MAEIN 863018867
TRUST SCORE
91
High Trust
10
FY2024 H1B Approvals
10
All-time Approvals
91
Trust Score / 100

TOP SPONSORED JOB CATEGORIES

Biochemists and BiophysicistsMolecular and Cellular BiologistsQuality Control Systems Managers

RECENT H1B FILINGS

JOB TITLELOCATIONWAGEDATE
Molecular and Cellular BiologistsCambridge, MA$90,000Oct 2025
Biochemists and BiophysicistsCambridge, MA$140,000Oct 2025
Molecular and Cellular BiologistsCambridge, MA$95,000Aug 2025
Marketing ManagersCambridge, MA$300,000Mar 2025
Biochemists and BiophysicistsCambridge, MA$140,000Feb 2025
Molecular and Cellular BiologistsCambridge, MA$76,612.6Feb 2025
Biochemists and BiophysicistsCambridge, MA$126,612.6Feb 2025
Biochemists and BiophysicistsCambridge, MA$101,610.6Dec 2024
Natural Sciences ManagersCambridge, MA$260,000Oct 2024
Natural Sciences ManagersCambridge, MA$260,000Oct 2024
Quality Control Systems ManagersCambridge, MA$105,000Oct 2024
Quality Control Systems ManagersCambridge, MA$105,000Oct 2024

SHOWING 50 MOST RECENT · SOURCE: DOL LCA PUBLIC DATA FY2024 · EIN 863018867

FREQUENTLY ASKED QUESTIONS

Does GARUDA THERAPEUTICS, INC. sponsor H1B visas?

Yes. GARUDA THERAPEUTICS, INC. has an active H1B sponsorship history with 10 total approved LCA filings on record, including 10 approvals in FY2024. Data sourced from US Department of Labor public disclosure files.

How many H1B visas has GARUDA THERAPEUTICS, INC. sponsored?

According to DOL LCA data, GARUDA THERAPEUTICS, INC. has 10 all-time H1B approvals and 10 approvals in fiscal year 2024.

What types of roles does GARUDA THERAPEUTICS, INC. sponsor H1B for?

GARUDA THERAPEUTICS, INC. most commonly sponsors H1B visas for: Biochemists and Biophysicists, Molecular and Cellular Biologists, Quality Control Systems Managers. This is based on their DOL Labor Condition Application filing history.

Is GARUDA THERAPEUTICS, INC. a reliable H1B sponsor?

GARUDA THERAPEUTICS, INC. has a Trust Score of 91/100 on KEEL, calculated from total approval volume, recency of filings, and approval consistency based on DOL LCA data.

DATA SOURCE: US DEPT. OF LABOR · LCA PUBLIC DISCLOSURE FY2023–FY2024